Details for New Drug Application (NDA): 020497
✉ Email this page to a colleague
The generic ingredient in FARESTON is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.
Summary for 020497
Tradename: | FARESTON |
Applicant: | Kyowa Kirin |
Ingredient: | toremifene citrate |
Patents: | 0 |
Pharmacology for NDA: 020497
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 020497
Suppliers and Packaging for NDA: 020497
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FARESTON | toremifene citrate | TABLET;ORAL | 020497 | NDA | Kyowa Kirin, Inc. | 42747-327 | 42747-327-30 | 30 TABLET in 1 BOTTLE (42747-327-30) |
FARESTON | toremifene citrate | TABLET;ORAL | 020497 | NDA | Kyowa Kirin, Inc. | 42747-327 | 42747-327-72 | 7 TABLET in 1 BLISTER PACK (42747-327-72) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 60MG BASE | ||||
Approval Date: | May 29, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020497
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kyowa Kirin | FARESTON | toremifene citrate | TABLET;ORAL | 020497-001 | May 29, 1997 | 4,696,949 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription